Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2b Randomized, Double-blind Study to Evaluate the Efficacy of MEDI7510 for the Prevention of Acute Respiratory Syncytial Virus-associated Respiratory Illness in Older Adults

NCT02508194 is registered in ClinicalTrials.gov with MedImmune LLC as lead sponsor.

NCT NCT02508194
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02508194 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2b Randomized, Double-blind Study to Evaluate the Efficacy of MEDI7510 for the Prevention of Acute Respiratory Syncytial Virus-associated Respiratory Illness in Older Adults
Lead sponsor
MedImmune LLC
Phase
Phase 2
Overall status
Terminated
Start date
September 29, 2015
Completion date
November 7, 2016
Enrollment
1,900 (actual)
Sites
61

Conditions

As the registry lists them; a condition with its own page is linked.

respiratory syncytial virus